Mobile App

Google Play Apple Store
Conversations in IFN-y Driven Diseases: Decoding the Gamma Signal
AMA/ABS/ANCC/ACPE Activity

Patients with interferon gamma (IFN-γ) driven diseases such as hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS) face significant diagnostic and therapeutic challenges, with delays in diagnosis and limited effective treatments often resulting in poor outcomes. Despite advances in understanding the role of IFN-γ in these conditions, there remains an unmet need for more precise diagnostic tools and faster, targeted therapies to manage the hyperinflammatory states that characterize these diseases.

Review the activity and claim AMA, ABS, ANCC or ACPE credit/contact hour after completion of a brief pretest and posttest/evaluation.











 
Scott Canna, MD Scott Canna, MD
Assistant Professor of Pediatrics
Childrens Hospital of Philadelphia

Pui Lee, MD Pui Lee, MD
Assistant Professor of Pediatrics
Boston Childrens Hospital

Ashish Kumar, MD, PhD Ashish Kumar, MD, PhD
Professor of Pediatrics
Cincinnati Children’s Hospital Medical Center

20
Supported by an independent educational grant from
Sobi, Inc.

Launch Date: November 14, 2024
Release Date: November 14, 2024
Expiration Date: October 31, 2025

Mini Module
7830
Conversations_IFN-Y_1730x162.png
True
Hematology

CookieConsent

Change Settings